ResearchIn-Press PreviewOphthalmologyVascular biology
Open Access |
10.1172/jci.insight.200679
1Department of Ophthalmology, University of California San Diego, San Diego, United States of America
2Department of Ophthalmology, University of California San Diego, San Diego, Japan
3Lowy Medical Research Institute, La Jolla, United States of America
4Department of Pharmacology and Neurosciences, University of California San Diego, San Diego, United States of America
Find articles by
Marra, K.
in:
PubMed
|
Google Scholar
|
1Department of Ophthalmology, University of California San Diego, San Diego, United States of America
2Department of Ophthalmology, University of California San Diego, San Diego, Japan
3Lowy Medical Research Institute, La Jolla, United States of America
4Department of Pharmacology and Neurosciences, University of California San Diego, San Diego, United States of America
Find articles by Murakami, T. in: PubMed | Google Scholar
1Department of Ophthalmology, University of California San Diego, San Diego, United States of America
2Department of Ophthalmology, University of California San Diego, San Diego, Japan
3Lowy Medical Research Institute, La Jolla, United States of America
4Department of Pharmacology and Neurosciences, University of California San Diego, San Diego, United States of America
Find articles by Chen, J. in: PubMed | Google Scholar
1Department of Ophthalmology, University of California San Diego, San Diego, United States of America
2Department of Ophthalmology, University of California San Diego, San Diego, Japan
3Lowy Medical Research Institute, La Jolla, United States of America
4Department of Pharmacology and Neurosciences, University of California San Diego, San Diego, United States of America
Find articles by Aguilar, E. in: PubMed | Google Scholar
1Department of Ophthalmology, University of California San Diego, San Diego, United States of America
2Department of Ophthalmology, University of California San Diego, San Diego, Japan
3Lowy Medical Research Institute, La Jolla, United States of America
4Department of Pharmacology and Neurosciences, University of California San Diego, San Diego, United States of America
Find articles by Robinson, J. in: PubMed | Google Scholar
1Department of Ophthalmology, University of California San Diego, San Diego, United States of America
2Department of Ophthalmology, University of California San Diego, San Diego, Japan
3Lowy Medical Research Institute, La Jolla, United States of America
4Department of Pharmacology and Neurosciences, University of California San Diego, San Diego, United States of America
Find articles by Prenner, M. in: PubMed | Google Scholar
1Department of Ophthalmology, University of California San Diego, San Diego, United States of America
2Department of Ophthalmology, University of California San Diego, San Diego, Japan
3Lowy Medical Research Institute, La Jolla, United States of America
4Department of Pharmacology and Neurosciences, University of California San Diego, San Diego, United States of America
Find articles by Daneman, R. in: PubMed | Google Scholar
1Department of Ophthalmology, University of California San Diego, San Diego, United States of America
2Department of Ophthalmology, University of California San Diego, San Diego, Japan
3Lowy Medical Research Institute, La Jolla, United States of America
4Department of Pharmacology and Neurosciences, University of California San Diego, San Diego, United States of America
Find articles by Friedlander, M. in: PubMed | Google Scholar
1Department of Ophthalmology, University of California San Diego, San Diego, United States of America
2Department of Ophthalmology, University of California San Diego, San Diego, Japan
3Lowy Medical Research Institute, La Jolla, United States of America
4Department of Pharmacology and Neurosciences, University of California San Diego, San Diego, United States of America
Find articles by Nudleman, E. in: PubMed | Google Scholar
Published June 2, 2026 - More info
Vascular tortuosity (VT) is a critical biomarker of disease progression and decision to treat ischemic retinal disorders, particularly retinopathy of prematurity (ROP). The murine oxygen-induced retinopathy model is the most widely-used model of ischemic retinopathy. Although VT has been described in OIR, its temporal dynamics have not been systematically defined. In this study, a semi-automated artificial intelligence (AI)-based pipeline was used to quantify VT throughout OIR. Retinal flat mounts from age-matched normoxic and OIR mice (postnatal days [P]10-P56) underwent vessel segmentation using a generative adversarial network (GAN), and VT was quantified as a cumulative tortuosity index (CTI) with the iROP-Assist algorithm. Concurrently, standard OIR outcomes of neovascularization (NV) and vaso-obliteration (VO) were quantified using OIRseg.org. NV peaked at P17 and resolved by P23, while VO regressed over a similar interval. VT peaked with NV at P17 but remained elevated through P56. These temporal changes mirror both the development of VT and its persistence after NV regression observed clinically in ROP. Collectively, these findings establish VT as a durable, quantifiable phenotype in OIR and expand the model’s utility beyond neovascular endpoints, providing a translational platform for investigating VT pathogenesis and evaluating the effects of therapeutic agents on vascular tortuosity.